Birmingham, West Midlands -- (SBWIRE) -- 01/22/2014 -- Value Penny Stocks issues special report on Vical Incorporated (NASDAQ:VICL), Athersys, Inc. (NASDAQ:ATHX), Antares Pharma Inc (NASDAQ:ATRS), Prana Biotechnology Limited (ADR) (NASDAQ:PRAN).
Vical Incorporated (NASDAQ:VICL) closed at the price of $1.66 after opening at $1.68. The stock traded during its last trading session with the total volume of 2,037,665 shares, as compared to its average volume of 1.99million shares. Vical Incorporated engages in the research and development of biopharmaceutical products based on its DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases.
Will VICL Continue To Move Higher? Find Out Here
Athersys, Inc. (NASDAQ:ATHX) remained among the day advancers and traded with volume of 2,035,467 shares in the last session, as compared to average volume of 2.22million shares. In comparison with 52 week range of $1.20 - $4.33, it faced lowest price of $4.10 during the last trading session whereas its day highest price was $4.23. The company’s total market capitalization is $251.13 million, along with 60.22million shares outstanding. Athersys, Inc, a biotechnology company, focuses on the research and development in the field of regenerative medicine.
Why Should Investors Buy ATHX After The Recent Gain? Just Go Here and Find Out
Antares Pharma Inc (NASDAQ:ATRS) showed 2,031,527 shares in volume during the last trading session, while the average trading volume remained 1.47million shares. The stock kicked off its trading session at $4.83 and closed at $4.95 after mounting 2.48%. Antares Pharma, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies, and topical gel-based medicines worldwide.
For How Long ATRS will Fight for Profitability? Read This Trend Analysis report
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) stock traded during its last trading session with the total traded volume of 2,008,715 shares versus its average volume of 714,668 shares. The company opened its trade at the price of $7.20 and its closing price was $8.28 after gaining 16.62% for the day. Prana Biotechnology Limited researches and develops therapeutic drugs for the treatment of neurological disorders in Australia.
Why Should Investors Buy PRAN After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)